Assessment of Cancer-Related Cognitive Impairments Across Anti-Cancer Therapies in a Predominantly Breast Cancer Cohort.
CRCI may occur during certain types of chemotherapy but appears to ameliorate over time, and Ongoing endocrine therapy may have longer-lasting impact on cognitive function.